Avian Pathogenic Escherichia coli (APEC) in Poultry: Clinical Diagnosis and Control Strategies

Introduction

Avian pathogenic Escherichia coli (APEC) represents a major etiological agent of colibacillosis, a complex disease syndrome responsible for substantial economic losses in the global poultry industry [1, 2, 58]. APEC strains belong to the extraintestinal pathogenic E. coli (ExPEC) pathotype and share significant genetic similarities with human ExPEC, raising concerns about zoonotic potential and food chain transmission [3, 70]. The pathogenicity of APEC is multifactorial, involving a wide array of virulence factors that enable colonization, immune evasion, and systemic dissemination [4, 70].

This article provides an exhaustive review of APEC in poultry, focusing on clinical diagnosis and control strategies. It integrates molecular epidemiology, virulence mechanisms, antimicrobial resistance (AMR) patterns, and emerging therapeutic approaches. The discussion emphasizes broiler and layer production systems, drawing on recent genomic surveillance studies and in vivo experimental models.

Classification and Serotypes

APEC strains exhibit considerable serotypic diversity. Globally, serogroups O1, O2, and O78 have historically been predominant [24, 36, 73]. However, longitudinal surveillance reveals shifting serogroup distributions. In the United States (Georgia), emerging serogroups such as O25, O8, O86, and O18 have been identified alongside classical types, with O25 associated with broilers and O1 with broiler breeders [24, 88]. Similarly, studies in China indicate that O145 has become the most prevalent serotype in certain regions, followed by O78, O8, and O111 [56, 57]. Serogroup O8 also dominates in Hainan Wenchang chicken embryos [90]. In Brazil, O78 remains common, but high-risk APEC pathotypes (HR-APEC) defined by ompT and hlyF carriage are increasingly recognized [5].

Phylogenetic classification places APEC isolates predominantly in groups A, B1, B2, D, F, and G [6, 24]. Minor phylogroups (B2, D, F, G) tend to harbor more virulence genes and ColV plasmids [6]. Multilocus sequence typing (MLST) has identified sequence types (STs) such as ST117, ST95, ST23, ST131, and ST140 as globally disseminated [36, 74]. ST117 is particularly notable for its association with both avian and human disease [36, 71].

Pathogenesis and Virulence Factors

APEC pathogenesis involves a multistep process: adhesion to respiratory or intestinal epithelium, invasion, resistance to serum complement and phagocytes, iron acquisition, and toxin-mediated tissue damage [4, 2, 70]. Key virulence factors are summarized in Table 1.

Table 1. Major Virulence Factors of APEC and Their Functions

Biofilm formation is a critical phenotype contributing to APEC persistence in the environment and on poultry processing surfaces [8, 37, 48]. Regulatory networks involving the second messenger c-di-GMP, the transcription factor YbdO, and the BasS/BasR TCS modulate biofilm-associated genes such as csgD, bcsE, and pgaA [48, 53]. Acid resistance mechanisms, including the YbdO-mediated activation of hdeA and yqgB, allow APEC to survive passage through the gastrointestinal tract [48].

Clinical Signs and Pathological Lesions

Colibacillosis manifests in several clinical forms depending on the route of infection, bird age, and predisposing factors. In broilers, the most common presentation is respiratory colibacillosis, often following immunosuppressive or respiratory viral infections such as [Avian Influenza A(H5N1) in Poultry and Wild Birds](Avian Influenza A(H5N1) in Poultry and Wild Birds) or [Mycoplasma gallisepticum](Mycoplasma gallisepticum in Poultry: Chronic Respiratory Disease and Control Strategies) [2, 58]. Stress factors, including stocking density, poor ventilation, and corticosterone elevation, exacerbate susceptibility [9, 27].

Systemic infection leads to fibrinous polyserositis: perihepatitis, pericarditis, airsacculitis, peritonitis, and salpingitis in layers [10, 96]. In broiler breeders, APEC is associated with decreased egg production and egg-borne (vertical) transmission, resulting in first-week mortality in chicks [66, 91]. Bacterial chondronecrosis with osteomyelitis (BCO) is an increasingly recognized manifestation, causing lameness in broilers, and APEC is a major etiological agent for this condition [74].

Clinical diagnosis relies on gross pathology: typical lesions include a yellowish fibrinous exudate covering the liver, heart, and air sacs. Histopathological examination reveals heterophilic infiltration, fibrin deposition, and serosal inflammation [45, 96].

Diagnosis: Laboratory Methods

Accurate diagnosis is essential for implementing appropriate control measures. Diagnostic approaches are outlined in the workflow in Figure 1.

Figure 1. Diagnostic Workflow for APEC Detection and Characterization

graph TD
    A[Clinical Sample: Liver, lung, air sac, heart swab], > B[Culture on MacConkey / Blood Agar]
    B, > C[Biochemical Identification: IMViC, API20E]
    C, > D[APEC-specific PCR: virulence genes<br/>e.g., iroN, hlyF, iss, iutA, ompT]
    D, > E{APEC positive?}
    E, Yes, > F[Serotyping: O-antigen antisera<br/>or multiplex PCR]
    E, No, > G[Consider commensal/other pathogen]
    F, > H[Antimicrobial Susceptibility Testing: disk diffusion / MIC]
    H, > I[Phenotypic AMR profile]
    D, > J[Whole Genome Sequencing<br/>(optional for surveillance)]
    J, > K[MLST, plasmid typing, ARG/VF analysis]
    K, > L[Epidemiological tracking]

Bacteriological Culture and Identification

Isolation of E. coli from internal organs (liver, spleen, bone marrow) with lesions is diagnostic. Samples are plated on MacConkey agar and eosin methylene blue (EMB) agar; colonies appear pink (lactose fermenters) with a metallic sheen on EMB. Biochemical identification includes IMViC tests (indole+, methyl red+, Voges-Proskauer-, citrate-), or commercial kits like API 20E [10, 33]. A definitive APEC designation requires detection of virulence genes; not all E. coli from lesions are APEC [24, 28].

Molecular Detection of Virulence Genes

Multiplex PCR targeting APEC-associated virulence genes is a robust diagnostic tool. Commonly used markers include iroN (salmochelin receptor), hlyF (hemolysin), iss (increased survival protein), iutA (aerobactin receptor), and ompT (outer membrane protease) [7, 28]. Additional genes such as fimC, papC, ibeB, mat, and sitA are frequently included [11, 33]. Loop-mediated isothermal amplification (LAMP) assays for sitA, traT, and ompT offer rapid, field-deployable detection with results in under 35 minutes [12].

Whole genome sequencing (WGS) is increasingly used for comprehensive characterization, enabling identification of serogroups (O: H typing), MLST, resistance genes, and plasmid replicons [13, 28, 74]. Genomic studies have identified minimal marker sets (e.g., iroC + hlyF + O78 wzx) for rapid APEC classification [28].

Antimicrobial Susceptibility Testing

The Kirby-Bauer disk diffusion method or broth microdilution is used to determine AMR profiles, following CLSI guidelines for veterinary breakpoints [7, 14]. APEC isolates frequently exhibit multidrug resistance (MDR), defined as resistance to at least one agent in three or more antimicrobial classes [26]. Common resistance phenotypes include resistance to ampicillin, tetracycline, nalidixic acid, trimethoprim-sulfamethoxazole, and enrofloxacin [11, 6, 26]. Emerging resistance to extended-spectrum cephalosporins (CTX-M type ESBL) and colistin (MCR-1) is particularly concerning [25, 65].

Antimicrobial Resistance: Mechanisms and Epidemiology

APEC has become a reservoir of AMR determinants. Resistance genes commonly detected include blaTEM (beta-lactams), tet(A)/tet(B) (tetracyclines), sul1 (sulfonamides), qnrS (quinolones), aac(6')-lb-cr (aminoglycosides/fluoroquinolones), mcr-1 (colistin), and ESBL genes such as blaCTX-M-1 and blaSHV-12 [6, 14, 25, 26]. Plasmid-mediated resistance, especially through IncI1 and IncK plasmids encoding ESBLs, facilitates horizontal spread [25].

MDR rates vary geographically: in Nepal, 91.6% of isolates were MDR [26]; in China, 76.5% of isolates from Shandong were MDR [6]; in Bangladesh, all APEC isolates were MDR, with resistance to macrolides, penicillins, tetracyclines, and fluoroquinolones exceeding 90% [3, 14]. The overuse of antibiotics, including critically important drugs like ciprofloxacin and colistin, without veterinary prescription is a major driver in low- and middle-income countries [14].

Efflux pump systems, particularly AcrAB-TolC, contribute to MDR in APEC, and gene regulation by systems like the ArcA transcription factor modulates susceptibility to kanamycin and penicillin G through outer membrane protein expression [98, 132].

Control Strategies

Biosecurity and Management

Prevention of colibacillosis hinges on strict biosecurity: all-in/all-out production, proper ventilation, litter management, and minimization of stress factors (including co-infections with respiratory viruses or Mycoplasma gallisepticum) [23, 58]. Vaccination against predisposing viral agents such as [Avian Influenza A(H5N1)](Avian Influenza H5N1 in Poultry: Current Epidemiology, Rapid Molecular Detection, and Biosecurity Measures) and [Infectious Bursal Disease Virus](Infectious Bursal Disease Virus Variants) helps reduce secondary APEC infections.

Vaccination

Both inactivated (bacterin) and live attenuated vaccines have been developed. Traditional bacterins often target specific serogroups (O1, O2, O78) but offer limited cross-protection [56, 81]. Recent advances focus on multivalent vaccines using novel adjuvants (e.g., HMT13) that provide broader protection against circulating serogroups such as O36, O78, and O109 [67]. Mutant vaccines lacking lpxL and lpxM genes have reduced endotoxin content, improving safety while maintaining efficacy against O1, O2, and O78 challenges [77].

Reverse vaccinology approaches using core genome analysis of multiple APEC isolates have identified conserved antigens like PagP (a lipid A palmitoyltransferase) as promising candidates for universal vaccines [1]. Bacterial membrane vesicles (MVs) from LPS-modified strains (msbB deletion) have demonstrated cross-protective immunity against multiple serotypes [81]. Additionally, peptide-based and epitope-based vaccines are under investigation using machine learning for epitope prediction [102].

Bacteriophage Therapy

Phage therapy has emerged as a potent alternative to antibiotics, given increasing MDR rates. Lytic phages targeting APEC have been isolated from sewage, poultry litter, and slaughterhouse wastewater [15, 8, 75]. Phage cocktails, such as UPWr_E124 (comprising three phages: Krischvirus and Tequatrovirus isolates), effectively reduce APEC biofilms on stainless steel, 96-well plates, and chicken meat surfaces [8]. In vivo studies in broiler chickens and mice demonstrated that phages administered via drinking water or gastric gavage significantly reduced bacterial loads in lungs, blood, and bursa of Fabricius [16]. A four-phage cocktail (AC-01) showed high lytic activity against HR-APEC isolates, inhibiting 56.3% of tested strains [5].

Phage characterization includes transmission electron microscopy, whole genome sequencing (to confirm absence of virulence and resistance genes), host range determination, and stability assays under varying pH, temperature, and gastric conditions [50, 87]. Phages such as CABI-SEA 2301 (Seuratvirus) and vB_EcoM_CE1 (Tequatrovirus) have been proven safe and effective [50, 87]. However, thermostability at high temperatures remains a limitation for some phages, such as PhEcoAP90, which showed instability above 50°C [17].

Probiotics and Prebiotics

Probiotics, particularly Lactobacillus and Enterococcus strains isolated from chicken gut, inhibit APEC through competitive exclusion, production of organic acids (e.g., butyric acid), and modulation of the immune response [40, 44, 51, 127]. Lactocaseibacillus casei NK1 and Enterococcus faecium P4, C7, and 2S4 have been shown to improve growth performance, enhance antioxidant capacity, and reduce diarrhea and intestinal hemorrhage in APEC-challenged broilers [40, 44]. Butyric acid produced by Ligilactobacillus animalis binds to the bacterial membrane protein BamA, disrupting cell envelope integrity [51].

Prebiotics such as xylooligosaccharides (XOS) and their monomers (xylobiose, xylotriose, xylotetraose) modulate cecal microbiota composition, increase short-chain fatty acid production, and downregulate APEC virulence gene expression [54]. Chlorogenic acid, a plant-derived polyphenol, protects intestinal barrier integrity through anti-inflammatory and antioxidant effects, involving TLR4/MyD88 and Nrf2/HO-1 pathways [18]. Palygorskite, a clay mineral, has also shown protective effects on growth and liver function in APEC-challenged broilers [82].

Phytochemicals and Essential Oils

Essential oils and plant extracts exhibit direct antibacterial activity and synergism with antibiotics. Cinnamon essential oil (CEO) showed MIC50 values of 0.4-0.5 μL/mL against APEC serogroups O78, O2, O128, O139 [76]. Origanum vulgare hydroethanolic extract disrupts membrane integrity and inhibits ATPase activity, and works synergistically with ampicillin and tetracycline [85]. Thymol, carvacrol, and biogenic silver nanoparticles (bio-AgNP) showed significant in vitro activity, but in vivo effect was limited at therapeutic doses [52]. Baicalin-copper complex and baicalein inhibit biofilm formation primarily by interfering with adhesion and the AKT/NF-κB pathway [29, 60]. Piper betle leaf nanoemulsion containing hydroxychavicol exhibits rapid bactericidal activity, with molecular docking studies confirming binding to cell division proteins FtsZ, FtsA, and ZapE [30]. Deep eutectic solvent-based emulsions containing these compounds prevent biofilm development on stored chicken meat [111].

Immunostimulants and Feed Additives

Sheep bile acids supplemented in duckling diets improved growth performance and antioxidant capacity, while reducing intestinal inflammation and enriching beneficial microbiota in APEC-infected birds [72]. Corticosterone administration (modeling stress) altered splenic responses, enhancing heterophil activity and antimicrobial peptide production, suggesting that stress management can influence disease outcome [27].

Future Perspectives and Integrated Approaches

The control of APEC requires an integrated strategy combining rapid molecular diagnostics (PCR, LAMP, WGS) with targeted intervention measures. AMR surveillance models integrating phage sensitivity, resistance gene detection, and antibiotic susceptibility profiling are being developed to inform treatment decisions [17]. Biological foundation models applied to antimicrobial peptide discovery have identified novel peptides effective against MDR-APEC [19, 107]. Machine learning tools for predicting host tropism and pathogenicity are also advancing [102].

The emergence of high-risk APEC clones (e.g., ST117, ST131) with zoonotic potential underscores the need for One Health surveillance linking poultry, environmental, and human isolates [3, 71]. Co-infections with other pathogens, such as Salmonella enterica and Avian Influenza virus, require comprehensive diagnostic panels [134].

Conclusion

APEC remains a formidable pathogen in poultry due to its genetic diversity, multifaceted virulence, and escalating antimicrobial resistance. Molecular diagnostics, particularly PCR and WGS, enable rapid detection and characterization, forming the foundation of effective control programs. Vaccination development has progressed from serotype-specific bacterins to conserved antigen-based and membrane vesicle vaccines. Alternative strategies, including phage therapy, probiotics, prebiotics, and phytochemicals, offer promising tools to reduce antibiotic dependence. The integration of these approaches, supported by continual genomic surveillance and an understanding of host-pathogen interactions, is essential for sustainable management of colibacillosis in broilers and layers.

References

[1] Jia, L., Ye, X., Arick, M., et al. Reverse vaccinology and host-pathogen analysis reveal pagP as a potential universal vaccine candidate against avian pathogenic Escherichia coli in poultry. Journal of Applied Microbiology.

[2] Nawaz, S., Wang, Z., Zhang, Y., et al. Avian pathogenic Escherichia coli (APEC): current insights and future challenges. Poultry Science.

[3] Amin, M.B., Hoque, K.I., Sraboni, A.S., et al. P-1271. Occurrence of Avian Pathogenic Escherichia coli (APEC) with potential for human extraintestinal infections in poultry environments of Bangladesh. Open Forum Infectious Diseases.

[4] Dziva, F., Stevens, M. Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts. Avian Pathology.

[5] Norambuena, R., Rojas-Martínez, V., Tobar-Calfucoy, E., et al. Development of a bacteriophage cocktail with high specificity against high-risk avian pathogenic Escherichia coli. Poultry Science.

[6] Song, S., Wang, Y., Liu, Z., et al. Population Structure, Genomic Features, and Antibiotic Resistance of Avian Pathogenic Escherichia coli in Shandong Province and Adjacent Regions, China (2008–2023). Microorganisms.

[7] Lúcio, C.J., Hansen, P.H., Griebeler, J., et al. Virulence and Antimicrobial Resistance of Avian Pathogenic Escherichia coli (APEC) Isolates from Poultry in Brazil. Poultry.

[8] Śliwka, P., Sáez Moreno, D., Korzeniowski, P., et al. Avian pathogenic Escherichia coli-targeting phages for biofilm biocontrol in the poultry industry. Veterinary Microbiology.

[9] Chen, M., He, Y., Jia, Y., et al. Liver transcriptome response to avian pathogenic Escherichia coli infection in broilers with corticosterone treatment. Poultry Science.

[10] Sani, H., Iliyasu, M., Alhaji, S., et al. Virulence Phenotype of Avian Pathogenic Escherichia coli (APEC) and Prevalence of Colibacillosis among Poultry Birds in Bauchi Metropolis, Nigeria. *International Journal of TROPICAL DISEASE

[11] Li, F., Li, M.-Y., Nie, L., et al. Molecular Epidemiology and Antibiotic Resistance Associated with Avian Pathogenic Escherichia coli in Shanxi Province, China, from 2021 to 2023. Microorganisms.

[12] Kogovšek, P., Ambrožič-Avguštin, J., Dovč, A., et al. Loop-mediated isothermal amplification: rapid molecular detection of virulence genes associated with avian pathogenic Escherichia coli in poultry. Poultry Science.

[13] Wang, Y., Gohar, M., Morriso, B., et al. 386 Decoding poultry threats: Unveiling sequencing types, serogroups, and antimicrobial resistance of avian pathogenic Escherichia coli in Alberta, Canada. Journal of Animal Science.

[14] Hasan, B., Ali, M.Z., Rawlin, G. Avian Pathogenic Escherichia coli Isolated in Poultry Farms in Bangladesh that Use Antibiotics Extensively. Microbial Drug Resistance.

[15] Napit, R., Gurung, A., Chaudhary, A., et al. Rapid Isolation and Genomic Characterization of Sewage-Derived Bacteriophages Targeting Multidrug-Resistant Avian Pathogenic Escherichia coli in Poultry. bioRxiv.

[16] Sáez Moreno, D., Kuczkowski, M., Korzeniowski, P., et al. Application of UPWr_E124 phage cocktail for effective reduction of avian pathogenic Escherichia coli in mice and broiler chickens. Veterinary Microbiology.

[17] Rahimian, M., Deyhim, H., Shirazi-Zavaragh, S., et al. Phage Isolation, Characterization, and Antibiotic Resistance Profiling in Avian Pathogenic Escherichia coli: Integrating Data for a Possible Novel AMR Surveillance Model. Microbial Pathogenesis.

[18] Wei, L., Liu, X., Tan, Z., et al. Chlorogenic acid mitigates avian pathogenic Escherichia coli-induced intestinal barrier damage in broiler chickens via anti-inflammatory and antioxidant effects. Poultry Science.

[19] Demirsoy, E., Parkin, T.I., Dema, A.H., et al. Efficacy and safety evaluation of artificial intelligence-identified antimicrobial peptides for use against avian pathogenic Escherichia coli in the poultry industry. bioRxiv.

[20] Zhang, J., Cherbuin, J.D.R., Khan, M., et al. Complete genome sequences of three avian pathogenic Escherichia coli strains isolated from colibacillosis-affected poultry in Pakistan. Microbiology Resource Announcements.

[21] Amburn, B., Medrano, A., et al. Surveillance of Avian Pathogenic Escherichia coli in Poultry and Children in Remote Ecuador. Journal.